Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells

被引:0
|
作者
Lovorka Stojic
Zuzana Jasencakova
Carolina Prezioso
Alexandra Stützer
Beatrice Bodega
Diego Pasini
Rebecca Klingberg
Chiara Mozzetta
Raphael Margueron
Pier Lorenzo Puri
Dirk Schwarzer
Kristian Helin
Wolfgang Fischle
Valerio Orlando
机构
[1] Dulbecco Telethon Institute,Department of Oncology
[2] IRCCS Fondazione Santa Lucia,Biotech Research and Innovation Centre (BRIC)
[3] University of Cambridge,Laboratory of Chromatin Biochemistry
[4] Cancer Research UK Cambridge Research Institute,Department of Biology and Genetics for Medical Sciences
[5] University of Copenhagen,Department of Experimental Oncology
[6] Max Planck Institute for Biophysical Chemistry,Department of Chemical Biology/Protein Chemistry
[7] University of Milan,undefined
[8] European Institute of Oncology,undefined
[9] c/o IFOM-IEO Campus,undefined
[10] Leibniz-Institut fuer Molekulare Pharmakologie (FMP),undefined
[11] Universitè Paris Diderot Paris 7,undefined
[12] CNRS,undefined
[13] Curie Institute,undefined
[14] Unité de Génétique et Biologie du Développement,undefined
[15] The Sanford Burnham Institute,undefined
来源
关键词
C2C12 Cell; Myogenic Differentiation; Skeletal Muscle Differentiation; Chick Embryo Extract; Human Primary Myoblast;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells
    Stojic, Lovorka
    Jasencakova, Zuzana
    Prezioso, Carolina
    Stuetzer, Alexandra
    Bodega, Beatrice
    Pasini, Diego
    Klingberg, Rebecca
    Mozzetta, Chiara
    Margueron, Raphael
    Puri, Pier Lorenzo
    Schwarzer, Dirk
    Helin, Kristian
    Fischle, Wolfgang
    Orlando, Valerio
    EPIGENETICS & CHROMATIN, 2011, 4
  • [2] Spatial Distribution of Polycomb Repressive Complex 2 (PRC2)-Associated Genes and Therapeutic Targeting of EZH2 in Glioblastoma
    Rotman, Lauren Elana
    Rotman, Lauren
    Yamashita, Daisuke
    Elsayed, Galal
    Chagoya, Gustavo
    Bernstock, Joshua
    Ilyas, Adeel
    Mooney, James
    Yamaguchi, Shinobu
    Komarova, Svetlana
    Markert, James
    Nakano, Ichiro
    JOURNAL OF NEUROSURGERY, 2020, 132 (04) : 112 - 112
  • [3] Study of Novel Inhibitor of EZH2/PRC2 in Cancer Cells
    Murashima, Akihiro
    Shinjo, Keiko
    Katsushima, Keisuke
    Onuki, Tetsuo
    Ito, Akihiro
    Yoshida, Minoru
    Kondo, Yutaka
    CANCER SCIENCE, 2018, 109 : 1175 - 1175
  • [5] Identification of potential inhibitors for EZH2/PRC2 in cancer cells
    Murashima, Akihiro
    Shinjo, Keiko
    Dohi, Natsuki
    Katsushima, Keisuke
    Ito, Akihiro
    Onuki, Tetsuo
    Yoshida, Minoru
    Kondo, Yutaka
    CANCER SCIENCE, 2018, 109 : 621 - 621
  • [6] Exploring the role of EZH2 (PRC2) as epigenetic target
    Aier, Imlimaong
    Raj, Utkarsh
    2016 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB), 2016,
  • [7] THE POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) IN MACROPHAGES AND ATHEROSCLEROSIS
    Neele, A. E.
    Willemsen, L.
    Chen, H. -J.
    Gijbels, M. J. J.
    Roomen, C. P. A. A.
    Griffith, G. R.
    Van Der Velden, S.
    Hoeksema, M. A.
    Prange, K. H. M.
    Boshuizen, M. C.
    Van Den Bossche, J.
    Tool, A. T.
    Matlung, H. L.
    Van Den Berg, T. K.
    Lutgens, E.
    De Winther, M. P. J.
    ATHEROSCLEROSIS, 2021, 331 : E9 - E10
  • [8] THE POLYCOMB REPRESSIVE COMPLEX 2 (PRC2) IN MACROPHAGES AND ATHEROSCLEROSIS
    Kempkes, Rosalie
    Rief, Lea
    Van Roomen, Cindy
    Gijbels, Marion
    Griffith, Guillermo
    Vos, Winnie
    Bosmans, Laura
    Willemsen, Lisa
    Prange, Koen
    De Winther, Menno
    Neele, Annette
    ATHEROSCLEROSIS, 2024, 395
  • [9] Chromatin silencing complex EZH2/PRC2 modulates aggressive anaplastic thyroid cancer biology
    Mello, Diego C.
    Cristovao, Marcella M.
    Saito, Kelly C.
    Kimura, Edna T.
    Fuziwara, Cesar Seigi
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Misregulation Of The PRC2 Complex In CML Stem Cells Confers Sensitivity To An EZH2 Inhibitor
    Scott, Mary T.
    Korfi, Koorosh
    Gallipoli, Paolo
    Saffrey, Peter
    Jorgensen, Heather
    Cruz, Michelle
    Hamilton, Ashley
    Sinclair, Amy
    Crossan, Andrew
    Normant, Emmanuel
    Balasubramanian, Vidya
    Holyoake, Tessa L.
    Vetrie, David
    BLOOD, 2013, 122 (21)